What does Modalis Therapeutics Corporation do?
Modalis Therapeutics Corporation engages in the research and development of therapeutics to treat patients with serious genetic disorders. The company is developing therapies for genetic diseases using its proprietary CRISPR-GNDM an epigenome editing technology that combines dCas9. It also develops various…
What is Modalis Therapeutics Corporation's P/E and P/B ratio?
Modalis Therapeutics Corporation has a P/E ratio of -1.1 and a P/B ratio of 1.14.
What is Modalis Therapeutics Corporation's debt-to-equity ratio?
Modalis Therapeutics Corporation has a debt-to-equity ratio of 0.11.
How much does Modalis Therapeutics Corporation owe compared with what it owns?
Modalis Therapeutics Corporation owes ¥0.21 for every ¥1 it owns (balance sheet Jun 2026), which is low.
What is Modalis Therapeutics Corporation's Positivity rank?
Modalis Therapeutics Corporation is ranked #5,526 of 10,750 companies globally and #2,674 of 3,683 in Japan on PositoAI, with a Positivity Score of 21,280.
Does Modalis Therapeutics Corporation have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
Red flags (PosiRed) are not checked yet for companies in this market on PositoAI, so no result is shown for Modalis Therapeutics Corporation.
Where can I read the latest news about Modalis Therapeutics Corporation?
Recent headlines about Modalis Therapeutics Corporation from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Modalis Therapeutics Corporation have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Modalis Therapeutics Corporation's current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.